Medline ® Abstract for Reference 6
of 'Tumor necrosis factor-alpha inhibitors: An overview of adverse effects'
6
TI
Infectious complications associated with immunomodulating biologic agents.
AU
Koo S, Marty FM, Baden LR
SO
Infect Dis Clin North Am. 2010 Jun;24(2):285-306.
The armamentarium of biologic therapies targeting specific elements of the immune system is rapidly expanding. This review describes the spectrum of infectious complications associated to date with each of the immunomodulating biologic therapies approved by the US Food and Drug Administration.
AD
Division of Infectious Diseases, Brigham and Women's Hospital, 75 Francis Street, PBB-A4, Boston, MA 02115, USA. skoo@partners.org
PMID